Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 6, 2011, Pages 545-553

  West, Amy E ^a   Weinstein, Sally M ^a   Celio, Christine I ^a   Henry, David ^a   Pavuluri, Mani N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RISPERIDONE; VALPROATE SEMISODIUM;

ADOLESCENT; ADULT; AGGRESSION; ARTICLE; BEHAVIOR DISORDER; BIPOLAR DISORDER; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; AGGRESSION; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; BIPOLAR DISORDER; CHILD; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS; RISPERIDONE; VALPROIC ACID;

EID: 84555189943     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2010.0140     Document Type: Article

References (27)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
2. Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM: The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 16:665-670, 2006. (Pubitemid 46175422)
3. Barzman DH, McConville BJ, Masterson B, McElroy S, Sethuraman G, Moore K, Kahwaty A, Nelson D: Impulsive aggression with irritability and responsive to divalproex: A pediatric bipolar spectrum disorder phenotype? J Affect Disord 88:279-285, 2005. (Pubitemid 41446969)
4. Bates MP: The Child and Adolescent Functional Assessment Scale (CAFAS): Review and current status. Clin Child Fam Psychol Rev 4:63-84, 2001. (Pubitemid 33600035)
5. Bird HR, Camino GJ, Rubio-Stipec M, Ribera JC: Further measures of the psychometric properties of the Children's Global Assessment Scale. Arch Gen Psychiatry 44:821-824, 1987. (Pubitemid 17152884)
6. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, Esposito-Smythers C, Goldstein T, Ryan N, Keller M: Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The course and outcome of bipolar youth (COBY) study. Am J Psychiatry 166:795-804, 2009.
7. Blader JC, Schooler NR, Jensen PS, Pliszka SR, Kafantaris V: Ad-junctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry 166:1392-1401, 2009.
8. Donovan SJ, Stewart JW, Nunes EV, Quitkin FM, Parides M, Daniel W, Susser E, Klein DF: Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design. Am J Psychiatry 157:818-820, 2000. (Pubitemid 30249664)
9. Emslie GJ, Mayes TL, Laptook RS, Batt M: Predictors of response to treatment in children and adolescents with mood disorders. Psy-chiatr Clini North Am 26:435-456, 2003. (Pubitemid 36583572)
10. Fisher LD, Dixon DO, Herson J, Frankowski RK, Hearron MS, Peace KE: Intention to treat in clinical trials. In: Statistical Issues in Drug Research and Development. Edited by KE. Peace. NY: Marcel Dekker; 1990; pp. 331.
11. Geller B, Tillman R, Bolhofner K, Zimerman B: Child bipolar I disorder: Prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry 65:1125-1133, 2008.
12. Geller B, Zimerman B, Williams M, Frazier J: WASH-U-KSADS (Washington University at St. Louis Kiddie and Young Adult Schedule for Affective Disorders and Schizophrenia-Lifetime and Present Episode Version-DSM-IV St Loius: Washington University School of Medicine, 1994, revised 1996.
13. Hodges K, Wong MM: Use of The Child and Adolescent Functional Assessment Scale to predict service utilization and cost. J Ment Health Adm 24:278-290, 1997.
14. Kafantaris V, Coletti DJ, Dicker R, Padula G, Pollack S: Are childhood psychiatric histories of bipolar adolescents associated with family history, psychosis, and response to lithium treatment? J Affec Disord 51:153-164, 1998. (Pubitemid 29101689)
15. Kaufman J, Birmaher B, Brent D, Rao U: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997. (Pubitemid 27272932)
16. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 38:963, 1982.
17. MacMillian CM, Korndörfer SR, Rao S, Fleisher CA, Mezzacappa E, Gonzalez-Heydrich J: A comparison of divalproex and oxcarba-zepine in aggressive youth with bipolar disorder. J Psychiatr Pract 12:214-222, 2006. (Pubitemid 44180544)
18. Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, Akiskal HS: Predictors of treatment nonresponse in bipolar children and adolescents with manic or mixed episodes. J Child Adolesc Psy-chopharmacol 14:395-404, 2004. (Pubitemid 39473124)
19. Pavuluri MN, Bishop JR: Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia. Neu-ropsychiatr Dis Treat 4:55-68, 2008. (Pubitemid 351460980)
20. Pavuluri M, Henry D, Findling R, Parnes S, Carbray J, Mohammed T, Janicak P, Sweeney J: Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disord 12:593-605, 2010.
21. Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R: Preliminary studies of the reliability and validity of the Children's Depression Rating Scale. J Am Acad Child Psychiatry 23:191-197, 1984. (Pubitemid 14066113)
22. Scheffer RE, Kowatch RA, Carmody T, Rush AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 162:58-64, 2005. (Pubitemid 40095673)
23. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228, 1983.
24. Strober M, DeAntonio M, Schmidt-Lackner S, Freeman R, Lampert C, Diamond J: Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. J Affec Disord 51:145-151, 1998. (Pubitemid 29101688)
25. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133: 429-435, 1978. (Pubitemid 9006756)
26. Youngstrom EA, Danielson CK, Findling RL, Gracious BL, Calabrese JR: Factor structure of the young mania rating scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol 31:567-572, 2002. (Pubitemid 37110241)
27. Yudofsky SC: The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35-39, 1986. (Pubitemid 16185859)